NGM

NGM Biopharmaceuticals, Inc. NGM

Trading inactive

Net profit

EBITDA

P/E Ratio

Capitalization

Performance

Periode NGM KNTE PRTK ATYR GRAY PRDS DBTX SESN RVLP TRML
6M 83.33 % 108.66 % -1.76 % -68.90 % 467.01 % 80.17 % 82.53 % 25.76 % -96.93 % 185.80 %
YTD 23.20 % 6.43 % 19.89 % -73.91 % 864.91 % 20.44 % 136.63 % -1.60 % -97.55 % 132.07 %
1Y -60.91 % -6.85 % -26.64 % -68.71 % 366.10 % 9.55 % 22.14 % 6.04 % -98.08 % 69.20 %
3Y -94.33 % -90.19 % -54.12 % -41.04 % -66.67 % -79.80 % -72.77 % 16.44 % -99.54 % 97.93 %
5Y -89.65 % -93.21 % -75.19 % -41.04 % -66.67 % -79.80 % -72.77 % -58.08 % -99.60 % -70.52 %
10Y -89.52 % -93.21 % -91.08 % -41.04 % -66.67 % -79.80 % -72.77 % -94.20 % -99.65 % -70.52 %
From the beginning -89.52 % -93.21 % -95.11 % -41.04 % -66.67 % -79.80 % -72.77 % -94.20 % -99.65 % -70.52 %

Dividend

Paratek Pharmaceuticals, Inc.

Sesen Bio, Inc.

Tourmaline Bio, Inc.